What if you invested $1000 in BAX on Jan 1, 2020?
Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.
Historical Annual Returns
Over the past 20 years, Baxter International Inc. has delivered an average annual return of 3.5%. The stock peaked in 2017 with a massive +47.0% gain, while investors faced a downturn in 2022 (-40.3%). Overall, the stock finished in the green 11 times out of 20 years.
Avg Return
+3.5%
Win Rate
55%
11W - 9L
Best
+47.0%
2017
Worst
-40.3%
2022
Performance Consistency
About Baxter International Inc.
Visit Website ↗Baxter International Inc. is a global medical technology company that provides a broad portfolio of essential healthcare products. The company focuses on products and therapies to treat chronic and acute medical conditions, with a mission to save and sustain lives and elevate patient care.
Key Business Segments
Medical Products and Therapies
Offers intravenous (IV) solutions, infusion systems, renal care products, advanced surgical equipment, and parenteral nutrition therapies.
Healthcare Systems and Technologies
Provides a range of advanced surgical products and digital health solutions designed to optimize patient care and improve clinical outcomes.
Pharmaceuticals
Includes a portfolio of inhaled anesthetics, and other pharmaceutical products.
Key Innovations
- ✓Pioneered standardized intravenous therapy solutions, improving patient safety and care.
- ✓Introduced the 'Transfuso-Vac' blood collection system, a critical advancement in blood banking.
- ✓Developed the first commercially-built artificial kidney (dialysis system), revolutionizing renal care.
Historical Milestones
Baxter International is founded by Dr. Donald Baxter.
Introduces the 'Transfuso-Vac' blood collection system.
Introduces the first commercially-built artificial kidney.
Officially becomes Baxter International Inc.
Acquires Hillrom, a global medical technology provider.